Sino Biopharmaceutical Ltd
HKEX:1177
Sino Biopharmaceutical Ltd?
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
2.34
4.15
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does Sino Biopharmaceutical Ltd hold over its rivals?
What risks and challenges
does Sino Biopharmaceutical Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Sino Biopharmaceutical Ltd.
Provide an overview of the primary business activities
of Sino Biopharmaceutical Ltd.
What unique competitive advantages
does Sino Biopharmaceutical Ltd hold over its rivals?
What risks and challenges
does Sino Biopharmaceutical Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Sino Biopharmaceutical Ltd.
Provide P/S
for Sino Biopharmaceutical Ltd.
Provide P/E
for Sino Biopharmaceutical Ltd.
Provide P/OCF
for Sino Biopharmaceutical Ltd.
Provide P/FCFE
for Sino Biopharmaceutical Ltd.
Provide P/B
for Sino Biopharmaceutical Ltd.
Provide EV/S
for Sino Biopharmaceutical Ltd.
Provide EV/GP
for Sino Biopharmaceutical Ltd.
Provide EV/EBITDA
for Sino Biopharmaceutical Ltd.
Provide EV/EBIT
for Sino Biopharmaceutical Ltd.
Provide EV/OCF
for Sino Biopharmaceutical Ltd.
Provide EV/FCFF
for Sino Biopharmaceutical Ltd.
Provide EV/IC
for Sino Biopharmaceutical Ltd.
Show me price targets
for Sino Biopharmaceutical Ltd made by professional analysts.
What are the Revenue projections
for Sino Biopharmaceutical Ltd?
How accurate were the past Revenue estimates
for Sino Biopharmaceutical Ltd?
What are the Net Income projections
for Sino Biopharmaceutical Ltd?
How accurate were the past Net Income estimates
for Sino Biopharmaceutical Ltd?
What are the EPS projections
for Sino Biopharmaceutical Ltd?
How accurate were the past EPS estimates
for Sino Biopharmaceutical Ltd?
What are the EBIT projections
for Sino Biopharmaceutical Ltd?
How accurate were the past EBIT estimates
for Sino Biopharmaceutical Ltd?
Compare the revenue forecasts
for Sino Biopharmaceutical Ltd with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Sino Biopharmaceutical Ltd and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Sino Biopharmaceutical Ltd against its competitors.
Analyze the profit margins
(gross, operating, and net) of Sino Biopharmaceutical Ltd compared to its peers.
Compare the P/E ratios
of Sino Biopharmaceutical Ltd against its peers.
Discuss the investment returns and shareholder value creation
comparing Sino Biopharmaceutical Ltd with its peers.
Analyze the financial leverage
of Sino Biopharmaceutical Ltd compared to its main competitors.
Show all profitability ratios
for Sino Biopharmaceutical Ltd.
Provide ROE
for Sino Biopharmaceutical Ltd.
Provide ROA
for Sino Biopharmaceutical Ltd.
Provide ROIC
for Sino Biopharmaceutical Ltd.
Provide ROCE
for Sino Biopharmaceutical Ltd.
Provide Gross Margin
for Sino Biopharmaceutical Ltd.
Provide Operating Margin
for Sino Biopharmaceutical Ltd.
Provide Net Margin
for Sino Biopharmaceutical Ltd.
Provide FCF Margin
for Sino Biopharmaceutical Ltd.
Show all solvency ratios
for Sino Biopharmaceutical Ltd.
Provide D/E Ratio
for Sino Biopharmaceutical Ltd.
Provide D/A Ratio
for Sino Biopharmaceutical Ltd.
Provide Interest Coverage Ratio
for Sino Biopharmaceutical Ltd.
Provide Altman Z-Score Ratio
for Sino Biopharmaceutical Ltd.
Provide Quick Ratio
for Sino Biopharmaceutical Ltd.
Provide Current Ratio
for Sino Biopharmaceutical Ltd.
Provide Cash Ratio
for Sino Biopharmaceutical Ltd.
What is the historical Revenue growth
over the last 5 years for Sino Biopharmaceutical Ltd?
What is the historical Net Income growth
over the last 5 years for Sino Biopharmaceutical Ltd?
What is the current Free Cash Flow
of Sino Biopharmaceutical Ltd?
Discuss the annual earnings per share (EPS)
trend over the past five years for Sino Biopharmaceutical Ltd.
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
HK |
Sino Biopharmaceutical Ltd
HKEX:1177
|
52.8B HKD | 1.9 | ||
JP |
N
|
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
|
776 550.9T JPY | 4 211 733 |
|
US |
Eli Lilly and Co
NYSE:LLY
|
707.6B USD | 17.3 |
|
|
UK |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 578.3 |
|
|
DK |
Novo Nordisk A/S
CSE:NOVO B
|
2.6T DKK | 9.7 |
|
|
US |
Johnson & Johnson
NYSE:JNJ
|
348.5B USD | 4 |
|
|
US |
Merck & Co Inc
NYSE:MRK
|
252.3B USD | 4 |
|
|
CH |
Roche Holding AG
SIX:ROG
|
210B CHF | 3.6 |
|
|
UK |
AstraZeneca PLC
LSE:AZN
|
164.8B GBP | 4.1 |
|
|
CH |
Novartis AG
SIX:NOVN
|
176.3B CHF | 3.9 |
|
|
US |
Pfizer Inc
NYSE:PFE
|
149.7B USD | 2.5 |
|
Revenue Growth | P/S to Growth | |||||
---|---|---|---|---|---|---|
HK |
Sino Biopharmaceutical Ltd
HKEX:1177
|
Average P/S:
382 942
1.9
|
12%
|
0.2 | ||
JP |
N
|
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
|
4 211 733
|
7%
|
601 676.1 |
|
US |
Eli Lilly and Co
NYSE:LLY
|
17.3
|
28%
|
0.6 |
|
|
UK |
Dechra Pharmaceuticals PLC
LSE:DPH
|
578.3
|
9%
|
64.3 |
|
|
DK |
Novo Nordisk A/S
CSE:NOVO B
|
9.7
|
21%
|
0.5 |
|
|
US |
Johnson & Johnson
NYSE:JNJ
|
4
|
4%
|
1 |
|
|
US |
Merck & Co Inc
NYSE:MRK
|
4
|
6%
|
0.7 |
|
|
CH |
Roche Holding AG
SIX:ROG
|
3.6
|
5%
|
0.7 |
|
|
UK |
AstraZeneca PLC
LSE:AZN
|
4.1
|
10%
|
0.4 |
|
|
CH |
Novartis AG
SIX:NOVN
|
3.9
|
5%
|
0.8 |
|
|
US |
Pfizer Inc
NYSE:PFE
|
2.5
|
3%
|
0.8 |
|
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.